Neurogene (NGNE) Non-Current Assets (2013 - 2026)

Neurogene has reported Non-Current Assets for 14 years, with the latest figure at $16.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 13.27% year-over-year to $16.4 million; the trailing twelve-month figure through Mar 2026 stood at $68.9 million (down 13.76% YoY), and the FY2025 full-year result was $16.8 million, down 15.01% from the prior year.
• Non-Current Assets for Q1 2026 stood at $16.4 million, down from $16.8 million in the prior quarter.
• The five-year high for Non-Current Assets was $24.5 million in Q4 2022, with the low at $9.7 million in Q3 2023.
• Historically, Non-Current Assets has averaged $17.9 million across 5 years, with a median of $18.5 million in 2022.
• Annual changes were most pronounced in 2023 — Non-Current Assets tumbled 45.3% — and 2024, when it jumped 111.21%.
• Neurogene's Non-Current Assets stood at $24.5 million in 2022, then retreated by 9.46% to $22.2 million in 2023, then fell by 10.88% to $19.8 million in 2024, then declined by 15.01% to $16.8 million in 2025, then retreated by 2.61% to $16.4 million in 2026.
• The last three Non-Current Assets figures came in at $16.4 million (Q1 2026), $16.8 million (Q4 2025), and $17.3 million (Q3 2025), per Business Quant data.